Physician profile
Christopher S Chen
NPI 1982047031
$2,862.58
in general payments reported to CMS, 2019-2025
10 companies · $369 in 2025
The $369 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,023 · 2020: $22.15 · 2021: $102 · 2023: $147 · 2024: $198 · 2025: $369.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $715.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $714.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,295.37 | 2019-2021 | |
| Stryker Corporation | $832.27 | 2019-2025 | T2 Alpha, Mako |
| Merck Sharp & Dohme LLC | $317.44 | 2023-2025 | Verquvo, Winrevair, Capvaxive |
| Supreme Orthopedic Systems, LLC | $165.56 | 2024-2025 | |
| Janssen Pharmaceuticals, INC | $114.55 | 2019 | |
| Pacira Therapeutics, INC. | $50.93 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $32.63 | 2024 | |
| Axogen | $22.15 | 2020 | |
| Smith+Nephew, INC. | $17.61 | 2021 | |
| Boston Scientific Corporation | $14.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.